
Cleara is a biopharmaceutical R&D company dedicated to the discovery and development of therapies for irreparably damaged cells present in ~25% of cancers with high unmet need (IP filed through 2042). Cleara is a multi-asset company with additional assets in its pipeline for diseases caused by cellular scarring.
Address
UtrechtNetherlands